A detailed history of Teacher Retirement System Of Texas transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 21,694 shares of RVNC stock, worth $55,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,694
Previous 21,451 1.13%
Holding current value
$55,753
Previous $106,000 47.17%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.34 - $4.73 $568 - $1,149
243 Added 1.13%
21,694 $56,000
Q1 2024

May 06, 2024

BUY
$4.65 - $9.31 $9,737 - $19,495
2,094 Added 10.82%
21,451 $106,000
Q4 2023

Feb 07, 2024

SELL
$5.81 - $11.2 $26,162 - $50,433
-4,503 Reduced 18.87%
19,357 $170,000
Q3 2023

Oct 31, 2023

BUY
$11.47 - $25.07 $12,800 - $27,978
1,116 Added 4.91%
23,860 $274,000
Q2 2023

Jul 19, 2023

SELL
$24.7 - $37.61 $64,244 - $97,823
-2,601 Reduced 10.26%
22,744 $576,000
Q1 2023

May 12, 2023

BUY
$18.36 - $35.27 $465,334 - $893,918
25,345 New
25,345 $816,000
Q3 2022

Nov 03, 2022

SELL
$14.33 - $28.47 $8,626 - $17,138
-602 Reduced 5.73%
9,907 $267,000
Q2 2022

Aug 09, 2022

SELL
$11.52 - $20.4 $39,306 - $69,604
-3,412 Reduced 24.51%
10,509 $145,000
Q1 2022

May 09, 2022

BUY
$12.36 - $20.31 $12,125 - $19,924
981 Added 7.58%
13,921 $271,000
Q4 2021

Feb 10, 2022

BUY
$12.46 - $27.87 $25,318 - $56,631
2,032 Added 18.63%
12,940 $211,000
Q3 2021

Nov 09, 2021

BUY
$25.78 - $33.21 $95,411 - $122,910
3,701 Added 51.35%
10,908 $304,000
Q2 2021

Aug 05, 2021

BUY
$26.8 - $31.84 $193,147 - $229,470
7,207 New
7,207 $214,000
Q1 2018

May 08, 2018

SELL
$29.15 - $37.4 $207,577 - $266,325
-7,121 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$24.55 - $36.3 $174,820 - $258,492
7,121
7,121 $255,000

Others Institutions Holding RVNC

About Revance Therapeutics, Inc.


  • Ticker RVNC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,305,696
  • Market Cap $212M
  • Description
  • Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...
More about RVNC
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.